RECRUITING

Time to Move in Pregnancy Hyperglycemia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This randomized controlled crossover trial of 36 pregnant individuals with gestational diabetes (GDM) or gestational glucose intolerance (GGI) will: 1. Determine the effects of physical activity (PA) timing, specifically 30 minutes of moderate intensity walking or stepping in the morning (between 5am-9am, within 30-40 minutes of starting breakfast), versus late afternoon/evening (between 4pm-8pm, within 30-40 minutes of dinner) on glucose across the 24-hour cycle. 2. Explore the potential effects of the timing of PA on sleep and mood state.

Official Title

The Time to Move Randomized Crossover Trial

Quick Facts

Study Start:2023-12-06
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06125704

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Samantha Ehrlich, PhD
CONTACT
‪(865) 315-7880‬
sehrlic1@utk.edu
Jill Maples, PhD
CONTACT
jmaples1@utmck.edu

Principal Investigator

Samantha Ehrlich, PhD
PRINCIPAL_INVESTIGATOR
The University of Tennessee, Knoxville

Study Locations (Sites)

The University of Tennessee Medical Center
Knoxville, Tennessee, 37920
United States

Collaborators and Investigators

Sponsor: The University of Tennessee, Knoxville

  • Samantha Ehrlich, PhD, PRINCIPAL_INVESTIGATOR, The University of Tennessee, Knoxville

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-06
Study Completion Date2025-12

Study Record Updates

Study Start Date2023-12-06
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • GDM
  • Physical Activity
  • Hyperglycemia
  • Glucose Intolerance
  • Circadian Rhythm
  • Exercise